Published in Nanotoxicology on September 21, 2010
Toxic effects of the interaction of titanium dioxide nanoparticles with chemicals or physical factors. Int J Nanomedicine (2013) 0.80
Changes in cardiopulmonary function induced by nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.80
MCPIP1 Regulates Alveolar Macrophage Apoptosis and Pulmonary Fibroblast Activation After in vitro Exposure to Silica. Toxicol Sci (2016) 0.78
Titanium dioxide nanoparticles induce the expression of early and late receptors for adhesion molecules on monocytes. Part Fibre Toxicol (2016) 0.75
Maternal Engineered Nanomaterial Exposure Disrupts Progeny Cardiac Function and Bioenergetics. Am J Physiol Heart Circ Physiol (2016) 0.75
Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med (2008) 4.91
Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science (2010) 2.99
Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Natl Acad Sci U S A (2009) 2.61
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials (2011) 2.44
45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials (2005) 2.11
Effects of Na(+)/Ca(2+)-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. J Mol Cell Cardiol (2002) 2.00
Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger. J Mol Cell Cardiol (2004) 1.68
Characterisation of a soft elastomer poly(glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials (2008) 1.63
In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59
Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium current. Cardiovasc Res (2013) 1.57
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet (2004) 1.56
Targeting phospholamban by gene transfer in human heart failure. Circulation (2002) 1.55
Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med (2002) 1.50
SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol (2011) 1.40
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface (2009) 1.39
Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng (2006) 1.36
The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials (2008) 1.30
Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells (2006) 1.30
Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev (2010) 1.29
Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail (2012) 1.23
Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am J Physiol Heart Circ Physiol (2008) 1.22
Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol (2010) 1.22
High-resolution scanning patch-clamp: new insights into cell function. FASEB J (2002) 1.20
Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface (2011) 1.18
Myocardial tissue engineering. Br Med Bull (2008) 1.17
Ion channels in small cells and subcellular structures can be studied with a smart patch-clamp system. Biophys J (2002) 1.16
An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials (2010) 1.16
Ca2+ cycling and new therapeutic approaches for heart failure. Circulation (2010) 1.16
The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials (2012) 1.16
A novel Z-groove index characterizing myocardial surface structure. Cardiovasc Res (2006) 1.14
Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J (2003) 1.13
Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules (2006) 1.12
Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) (2002) 1.08
Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med (2012) 1.08
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation (2002) 1.07
Polyhydroxyalkanoates in Gram-positive bacteria: insights from the genera Bacillus and Streptomyces. Antonie Van Leeuwenhoek (2006) 1.07
The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. Cardiovasc Res (2008) 1.06
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J (2012) 1.05
Calcium phosphate-based composites as injectable bone substitute materials. J Biomed Mater Res B Appl Biomater (2010) 1.05
Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS One (2010) 1.02
PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: an in vitro cell biology assessment. Biomaterials (2004) 1.02
Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials (2004) 1.02
In vitro biocompatibility of 45S5 Bioglass-derived glass-ceramic scaffolds coated with poly(3-hydroxybutyrate). J Tissue Eng Regen Med (2009) 0.99
Scanning ion conductance microscopy: a convergent high-resolution technology for multi-parametric analysis of living cardiovascular cells. J R Soc Interface (2011) 0.98
Magnetic resonance imaging evaluation of remodeling by cardiac elastomeric tissue scaffold biomaterials in a rat model of myocardial infarction. Tissue Eng Part A (2010) 0.97
The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacol Ther (2006) 0.97
Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis (2007) 0.97
Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials (2008) 0.96
The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening. Br J Pharmacol (2013) 0.94
The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. Biomaterials (2011) 0.94
Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering. Acta Biomater (2010) 0.94
Processing and characterization of porous structures from chitosan and starch for tissue engineering scaffolds. Biomacromolecules (2006) 0.94
Altered mechanical properties and intracellular calcium signaling in cardiomyocytes from annexin 6 null-mutant mice. FASEB J (2002) 0.93
Biocompatibility and bone mineralization potential of 45S5 Bioglass-derived glass-ceramic scaffolds in chick embryos. Acta Biomater (2008) 0.93
Electrophoretic deposition of biological macromolecules, drugs, and cells. Biomacromolecules (2013) 0.93
Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem Biophys Res Commun (2006) 0.93
Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease. J Cell Mol Med (2009) 0.93
Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology. Br J Pharmacol (2004) 0.92
Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse. J Biol Chem (2011) 0.91
Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function. Biomaterials (2011) 0.90
In vitro attachment of Staphylococcus epidermidis to surgical sutures with and without Ag-containing bioactive glass coating. J Biomater Appl (2004) 0.89
Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase. Crit Care Med (2011) 0.89
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Cancer research by means of tissue engineering--is there a rationale? J Cell Mol Med (2013) 0.88
Permeability evaluation of 45S5 Bioglass-based scaffolds for bone tissue engineering. J Biomech (2008) 0.88
In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass. J Biomed Mater Res A (2005) 0.86
Premature degradation of poly(alpha-hydroxyesters) during thermal processing of Bioglass-containing composites. Acta Biomater (2009) 0.86
Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng Part C Methods (2013) 0.86
Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials (2010) 0.86
Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses. Expert Rev Med Devices (2006) 0.86
Surface functionalization of Bioglass-derived porous scaffolds. Acta Biomater (2007) 0.85
Gene transfer in cardiac myocytes. Surg Clin North Am (2004) 0.85
Functional characterization of embryonic stem cell-derived cardiomyocytes using scanning ion conductance microscopy. Tissue Eng (2006) 0.85
Toughening and functionalization of bioactive ceramic and glass bone scaffolds by biopolymer coatings and infiltration: a review of the last 5 years. Expert Rev Med Devices (2014) 0.84
Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Eng Part B Rev (2012) 0.84
Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective. Br J Clin Pharmacol (2013) 0.84
Chitosan membranes containing micro or nano-size bioactive glass particles: evolution of biomineralization followed by in situ dynamic mechanical analysis. J Mech Behav Biomed Mater (2012) 0.84
Bone tissue engineering by using a combination of polymer/Bioglass composites with human adipose-derived stem cells. Cell Tissue Res (2014) 0.84
Bioactivity of degradable polymer sutures coated with bioactive glass. J Mater Sci Mater Med (2004) 0.84
45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay. Tissue Eng Part A (2013) 0.83
Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites. J R Soc Interface (2009) 0.83
Reinforcement of calcium phosphate cement with multi-walled carbon nanotubes and bovine serum albumin for injectable bone substitute applications. J Mech Behav Biomed Mater (2010) 0.83
Osteogenic differentiation of human dental pulp stromal cells on 45S5 Bioglass® based scaffolds in vitro and in vivo. Tissue Eng Part A (2012) 0.82
A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med (2015) 0.82
SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope. Br J Pharmacol (2014) 0.82
Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J Control Release (2011) 0.82
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface (2015) 0.82
Characterisation of bioactive and resorbable polylactide/Bioglass composites by FTIR spectroscopic imaging. Biomaterials (2004) 0.81
Behavior of encapsulated MG-63 cells in RGD and gelatine-modified alginate hydrogels. Tissue Eng Part A (2014) 0.81